Unichem Laboratories Statistics
Total Valuation
NSE:UNICHEMLAB has a market cap or net worth of INR 43.62 billion. The enterprise value is 44.64 billion.
Market Cap | 43.62B |
Enterprise Value | 44.64B |
Important Dates
The next estimated earnings date is Thursday, May 22, 2025.
Earnings Date | May 22, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.14% |
Shares Change (QoQ) | +0.08% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 20.07M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.29 |
PB Ratio | 1.82 |
P/TBV Ratio | 1.82 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -154.45 |
EV / Sales | 2.35 |
EV / EBITDA | 20.93 |
EV / EBIT | 44.50 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.13 |
Debt / EBITDA | 1.41 |
Debt / FCF | n/a |
Interest Coverage | 5.10 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 2.32% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 6.62M |
Profits Per Employee | -100,537 |
Employee Count | 2,875 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.35% in the last 52 weeks. The beta is 0.22, so NSE:UNICHEMLAB's price volatility has been lower than the market average.
Beta (5Y) | 0.22 |
52-Week Price Change | +4.35% |
50-Day Moving Average | 659.53 |
200-Day Moving Average | 681.80 |
Relative Strength Index (RSI) | 44.05 |
Average Volume (20 Days) | 74,153 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:UNICHEMLAB had revenue of INR 19.03 billion and -289.04 million in losses. Loss per share was -4.11.
Revenue | 19.03B |
Gross Profit | 11.26B |
Operating Income | 1.00B |
Pretax Income | -132.26M |
Net Income | -289.04M |
EBITDA | 2.08B |
EBIT | 1.00B |
Loss Per Share | -4.11 |
Balance Sheet
The company has 1.98 billion in cash and 3.00 billion in debt, giving a net cash position of -1.02 billion.
Cash & Cash Equivalents | 1.98B |
Total Debt | 3.00B |
Net Cash | -1.02B |
Net Cash Per Share | n/a |
Equity (Book Value) | 24.01B |
Book Value Per Share | 341.71 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 59.18%, with operating and profit margins of 5.27% and -1.52%.
Gross Margin | 59.18% |
Operating Margin | 5.27% |
Pretax Margin | -0.69% |
Profit Margin | -1.52% |
EBITDA Margin | 10.91% |
EBIT Margin | 5.27% |
FCF Margin | n/a |
Dividends & Yields
NSE:UNICHEMLAB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.14% |
Shareholder Yield | 0.14% |
Earnings Yield | -0.66% |
FCF Yield | n/a |
Stock Splits
The last stock split was on October 21, 2010. It was a forward split with a ratio of 2.5.
Last Split Date | Oct 21, 2010 |
Split Type | Forward |
Split Ratio | 2.5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |